Tracy Tschudi
Psychiatric/Mental Health · Dubuque, IANPI 1790013209
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 340 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,113 and has fallen 94.5% since, to $117 in 2023.
Across 340 payments — averaging $12.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$524
- Lundbeck LLC$457
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$437
- Alkermes, Inc.$384
- AbbVie$372
- Neurocrine Biosciences, Inc.$340
- plus $2K from 10 others
What the payments were for
- Food & beverage$4,18497%
- Education$1393%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 68 | $524 |
| Lundbeck LLC | 26 | $457 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 22 | $437 |
| Alkermes, Inc. | 25 | $384 |
| AbbVie | 22 | $372 |
| Neurocrine Biosciences, Inc. | 58 | $340 |
| Supernus Pharmaceuticals, Inc. | 24 | $320 |
| Otsuka America Pharmaceutical, Inc. | 26 | $310 |
| Sunovion Pharmaceuticals Inc. | 19 | $310 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $300 |
| Vanda Pharmaceuticals Inc. | 11 | $179 |
| Teva Pharmaceuticals USA, Inc. | 10 | $167 |
| Axsome Therapeutics, Inc. | 1 | $77 |
| Ironshore Pharmaceuticals Inc. | 4 | $61 |
| Indivior Inc. | 4 | $59 |
| Corium, LLC | 2 | $27 |
How this compares
$4,323 in reported general payments places this provider in the 85th percentile of 443 psychiatric/mental health providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 171 | $82,685 |
| CaplytaLumateperone Tosylate | 36 | $57,877 |
| Lurasidone Hcl | 32 | $28,508 |
| Risperdal ConstaRisperidone Microspheres | 22 | $27,955 |
| Invega SustennaPaliperidone Palmitate | 11 | $25,071 |
| RexultiBrexpiprazole | 16 | $23,027 |
| LybalviOlanzapine/Samidorphan Malate | 15 | $22,957 |
| Aripiprazole | 85 | $17,197 |
| LamictalLamotrigine | 13 | $8,922 |
| VyvanseLisdexamfetamine Dimesylate | 13 | $4,957 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 20 | $3,681 |
| Bupropion XlBupropion Hcl | 224 | $3,612 |
| Oxcarbazepine | 28 | $2,897 |
| Vilazodone Hcl | 17 | $1,824 |
| Memantine Hcl | 21 | $1,795 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $300 | $87,642184 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $437 | $57,87736 claims |
| Johnson & JohnsonRisperdal Consta, Invega Sustenna | $524 | $53,02633 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $310 | $23,02716 claims |
| Alkermes, Inc.Lybalvi | $384 | $22,95715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 443 psychiatric/mental health providers in Iowa.
Other psychiatric/mental health in Dubuque
- Mindy RobertsDubuque$6K
- Jessica DunneDubuque$4K
- Jenni McCannDubuque$4K
- Tarrah HollidayAtlantic$421K
- Kelsie SwisherParkersburg$235K
- Jennifer BradleyCedar Rapids$66K
- Kama AusbornWaterloo$64K
- Quentin ChambersDes Moines$40K
- Tenaea JeppesonFort Dodge$38K
- Jennifer WittmanCoralville$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.